Shenmeng Gao

1.8k total citations
49 papers, 1.2k citations indexed

About

Shenmeng Gao is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Shenmeng Gao has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 18 papers in Cancer Research and 17 papers in Hematology. Recurrent topics in Shenmeng Gao's work include MicroRNA in disease regulation (13 papers), Acute Myeloid Leukemia Research (11 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). Shenmeng Gao is often cited by papers focused on MicroRNA in disease regulation (13 papers), Acute Myeloid Leukemia Research (11 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). Shenmeng Gao collaborates with scholars based in China and United States. Shenmeng Gao's co-authors include Jianbo Wu, Chongyun Xing, Chiqi Chen, Fujun Yu, Peihong Dong, Bin Zhou, Jianjian Zheng, Haiying Li, Zhongqiu Lu and Xiaoqu Hu and has published in prestigious journals such as Blood, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Shenmeng Gao

47 papers receiving 1.2k citations

Peers

Countries citing papers authored by Shenmeng Gao

Since Specialization

Citations

This map shows the geographic impact of Shenmeng Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenmeng Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenmeng Gao more than expected).

Fields of papers citing papers by Shenmeng Gao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenmeng Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenmeng Gao. The network helps show where Shenmeng Gao may publish in the future.

Co-authorship network of co-authors of Shenmeng Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Shenmeng Gao. A scholar is included among the top collaborators of Shenmeng Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenmeng Gao. Shenmeng Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	miR-182 promoter hypermethylation predicts the better outcome of AML patients treated with AZA + VEN in a real-world setting 2025 ·Clinical Epigenetics ·(unknown), Danyang Li, Na Wang, (unknown), Meng Chen, Min Zhao, Zihan Lin, Min Li, (unknown), (unknown), (unknown), Shenmeng Gao, (unknown)	1
2	Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemia 2024 ·Experimental Hematology and Oncology ·Shuya Feng, (unknown), Zihan Lin, Min Li, (unknown), (unknown), Danyang Li, Min Zhao, Meng Chen, (unknown), Shanshan Wu, Fang Xiong, (unknown), Junjun Yang, (unknown), (unknown), Shenmeng Gao	19
3	Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax 2024 ·Clinical Epigenetics ·Danyang Li, (unknown), Meng Chen, Zihan Lin, Min Zhao, (unknown), Min Li, (unknown), (unknown), Xiaofei He, (unknown), Shujuan Zhou, Haixia Zhou, Shenmeng Gao	4
4	Lipase-triggered drug release from BCL2 inhibitor ABT-199-loaded nanoparticles to elevate anti-leukemic activity through enhanced drug targeting on the mitochondrial membrane 2022 ·Acta Biomaterialia ·Bin Liang, Dawei Jiang, (unknown), Fang Xiong, Shuya Feng, (unknown), (unknown), Zhijie Yu, Changcan Shi, Shenmeng Gao	7
5	DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax 2022 ·Theranostics ·Sisi Ye, Fang Xiong, Xiaofei He, (unknown), Danyang Li, (unknown), (unknown), Zihan Lin, Min Zhao, Shuya Feng, Bin Zhou, Huachun Weng, (unknown), (unknown), Shenmeng Gao	19
6	Higher Red Blood Cell Distribution Width is a Poor Prognostic Factor for Patients with Chronic Myeloid Leukemia 2021 ·Cancer Management and Research ·Tao Li, Xin Li, Hui Chen, (unknown), Qi Xie, (unknown), Shenmeng Gao, Jianhua Feng, (unknown), Zhanguo Chen, Xiaoqun Zheng	4
7	A regulatory circuitry between miR-193a/miR-600 and WT1 enhances leukemogenesis in acute myeloid leukemia 2018 ·Experimental Hematology ·Haiying Li, Chongyun Xing, Bin Zhou, (unknown), Jianhua Feng, Jianbo Wu, Shenmeng Gao	16
8	Long noncoding RNA HOTAIR promotes the self-renewal of leukemia stem cells through epigenetic silencing of p15 2018 ·Experimental Hematology ·Shenmeng Gao, Bin Zhou, Haiying Li, (unknown), Yanfei Wu, Chongyun Xing, (unknown), (unknown)	47
9	A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia 2018 ·BMC Cancer ·Laixi Bi, Bin Zhou, Haiying Li, Licai He, Chunjing Wang, (unknown), (unknown), Mengqian Chen, Shenmeng Gao	53
10	Mebendazole exhibits potent anti-leukemia activity on acute myeloid leukemia 2018 ·Experimental Cell Research ·Licai He, (unknown), (unknown), He Huang, Rui Gong, Lan Ma, (unknown), Shenmeng Gao, Jianxin Lyu, Haihua Gu	17
11	Honokiol induces proteasomal degradation of AML1-ETO oncoprotein via increasing ubiquitin conjugase UbcH8 expression in leukemia 2016 ·Biochemical Pharmacology ·Bin Zhou, Haiying Li, Chongyun Xing, (unknown), Jianhua Feng, Jianbo Wu, Zhongqiu Lu, Jing Fang, Shenmeng Gao	20
12	Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers 2016 ·Journal of Experimental & Clinical Cancer Research ·Junjie Chen, Shenmeng Gao, Chunjing Wang, (unknown), Huxiang Zhang, Kate Huang, Bin Zhou, Haiying Li, Zhijie Yu, Jianbo Wu, (unknown)	27
13	Effect of initial absolute monocyte count on survival outcome of patients with de novo non-M3 acute myeloid leukemia 2016 ·Leukemia & lymphoma ·Jianhua Feng, Wei Zhang, Junqing Wu, Shenmeng Gao, (unknown), Lan Sun, Yi Chen, Kang Yu, Chongyun Xing	9
14	Suppression of collagen synthesis by Dicer gene silencing in hepatic stellate cells 2013 ·Molecular Medicine Reports ·Fujun Yu, Zhuo Lin, Jianjian Zheng, Shenmeng Gao, Zhongqiu Lu, Peihong Dong	10
15	Analysis of WT1 mutations, expression levels and single nucleotide polymorphism rs16754 inde novonon-M3 acute myeloid leukemia 2013 ·Leukemia & lymphoma ·(unknown), Kang Yu, (unknown), (unknown), (unknown), (unknown), Shenmeng Gao	14
16	Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer 2013 ·Molecular and Cellular Biochemistry ·Chiqi Chen, Chengshui Chen, Junjie Chen, (unknown), Honglei Xu, Weiwei Jin, Jianbo Wu, Shenmeng Gao	51
17	Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class Ι histone deacetylases 2013 ·Carcinogenesis ·Chiqi Chen, Kang Yu, (unknown), Chongyun Xing, Yi Chen, Yan Zhuang, Yifen Shi, Kewen Zhao, Shenmeng Gao	57
18	Inhibition of p38 MAPK activity in B-NHL Raji cells by treatment with engineered CD20-specific T cells 2011 ·Oncology Letters ·Lei Jiang, Kang Yu, Jimei Du, Wuhua Ni, Yixiang Han, Shenmeng Gao, Haiying Li, Jianbo Wu, Yihu Zheng, (unknown)	3
19	miR-15a and miR-16-1 inhibit the proliferation of leukemic cells by down-regulating WT1 protein level 2011 ·Journal of Experimental & Clinical Cancer Research ·Shenmeng Gao, Chongyun Xing, Chiqi Chen, Sisi Lin, Peihong Dong, Fujun Yu	59
20	Lentivirus-mediated overexpression of TGF-β inducible early gene 1 inhibits SW1990 pancreatic cancer cell growth 2011 ·Cell Biology International ·Lei Jiang, (unknown), Feiyan Lin, Shenmeng Gao, (unknown), Yixiang Han, Chiqi Chen, Jianbo Wu	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact